Michael Astrue

2013

In 2013, Michael Astrue earned a total compensation of $372.5K as Former Interim Chief Executive Officer at InVivo Therapeutics Holdings.

Compensation breakdown

Salary$138,461
Stock Awards$234,023
Total$372,484

Astrue received $234K in stock awards, accounting for 63% of the total pay in 2013.

Astrue also received $138.5K in salary.

Rankings

In 2013, Michael Astrue's compensation ranked 10,266th out of 12,286 executives tracked by ExecPay. In other words, Astrue earned more than 16.4% of executives.

ClassificationRankingPercentile
All
10,266
out of 12,286
16th
Division
Manufacturing
3,814
out of 4,612
17th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
539
out of 681
21st
Industry group
Surgical, Medical, And Dental Instruments And Supplies
328
out of 420
22nd
Industry
Surgical and Medical Instruments and Apparatus
204
out of 263
22nd
Source: SEC filing on April 29, 2015.

Astrue's colleagues

We found five more compensation records of executives who worked with Michael Astrue at InVivo Therapeutics Holdings in 2013.

2013

Brian Hess

InVivo Therapeutics Holdings

Chief Technology Officer

2013

Frank Reynolds

InVivo Therapeutics Holdings

Chief Executive Officer

2013

Sean Moran

InVivo Therapeutics Holdings

Chief Financial Officer

2013

Gregory Perry

InVivo Therapeutics Holdings

Chief Financial Officer

2013

Steven McAllister

InVivo Therapeutics Holdings

Chief Financial Officer

You may also like